Renal Cancer - Results from #180

On-clamp vs off-clamp robot-assisted partial nephrectomy for achieving modified trifecta: inverse probability of treatment weighting analysis from a high-volume tertiary robotic center. September 2, 2024

Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer. August 30, 2024

Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology. August 30, 2024

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. August 29, 2024

Renal Cell Carcinoma A Review August 28, 2024

Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma. August 28, 2024

APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression. August 28, 2024

The influence of sex hormones on renal cell carcinoma. August 26, 2024

Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma. August 26, 2024

Exploring the Feasibility of GPT-4 as a Data Extraction Tool for Renal Surgery Operative Notes. August 26, 2024

Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau". August 26, 2024

Validation of the Meet-URO score in metastatic clear cell renal cell carcinoma patients receiving second or third-line tyrosine kinase inhibitors-immune checkpoint inhibitors combination therapy. August 26, 2024

Recurrence patterns following nephrectomy for renal cell carcinoma in a Danish nationwide cohort. August 26, 2024

Use of Radiation Therapy for Ataxia-Telangiectasia Mutated (ATM)-Mutation Metastatic Renal Cell Carcinoma: A Case Report. August 26, 2024

Targeting multiple receptor tyrosine kinases with sitravatinib: A Phase 1b study in advanced renal cell carcinoma and castrate-resistant prostate cancer. August 23, 2024

Avelumab plus axitinib for first-line treatment of advanced renal cell carcinoma: A real-world ambispective RAVE-Renal study. August 22, 2024

Navigating the Nuances: Evaluating Avelumab and Axitinib in Metastatic Renal Cell Carcinoma Treatment August 22, 2024

Prognostic assessment of patients with bone metastatic renal cell cancer treated with palliative radiotherapy. August 22, 2024

The efficacy and safety of cabozantinib in patients with metastatic or advanced renal cell carcinoma: a systematic review and meta-analysis. August 22, 2024

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma. August 22, 2024

Page 10 of 456